Preformed EPC Plain Liposomes with 45 mol% CHOL
<strong>Preformed EPC Plain Liposomes with 45 mol% CHOL </strong>_x000D_ <strong>Catalog number:</strong> B2019459_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> Preformed EPC Plain Liposomes with 45 mol% CHOL_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Steenpass T, Lung A, Schubert R. Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes Biochim Biophys Acta. 2006 Jan;1758(1):20-8._x000D_ 2: Mahjoub MA, Dadashzadeh S, Haeri A, Shahhosseini S, Abbasian Z, Nowroozi F. Doxorubicin-Loaded Multivesicular Liposomes (DepoFoam) as a Sustained Release Carrier Intended for Locoregional Delivery in Cancer Treatment: Development, Characterization, and Cytotoxicity Evaluation Iran J Pharm Res. 2023 Feb 26;21(1):e134190._x000D_ 3: Reinish LW, Bally MB, Loughrey HC, Cullis PR. Interactions of liposomes and platelets Thromb Haemost. 1988 Dec 22;60(3):518-23._x000D_ 4: Lima AC, Reis RL, Ferreira H, Neves NM. Cellular Uptake of Three Different Nanoparticles in an Inflammatory Arthritis Scenario versus Normal Conditions Mol Pharm. 2021 Sep 6;18(9):3235-3246._x000D_ 5: Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel J Control Release. 2003 Sep 4;91(3):417-29._x000D_ 6: Ahmad I, Sarkar AK, Bachhawat BK. Effect of cholesterol in various liposomal compositions on the in vivo toxicity, therapeutic efficacy, and tissue distribution of amphotericin B Biotechnol Appl Biochem. 1990 Oct;12(5):550-6._x000D_ 7: Farzaneh H, Ebrahimi Nik M, Mashreghi M, Saberi Z, Jaafari MR, Teymouri M. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy Int J Pharm. 2018 Nov 15;551(1-2):300-308._x000D_ 8: Bally MB, Nayar R, Masin D, Cullis PR, Mayer LD. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes Cancer Chemother Pharmacol. 1990;27(1):13-9._x000D_ 9: Kashiwagi H, Ueno M. [Mechanism of micelle-vesicle transformation and control of vesicular sizes and properties] Yakugaku Zasshi. 2008 May;128(5):669-80._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/19582853">10: Tseng LP, Chiou CJ, Deng MC, Lin MH, Pan RN, Huang YY, Liu DZ. Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity J Biomed Mater Res B Appl Biomater. 2009 Nov;91(2):621-625. </a>_x000D_ _x000D_ <strong>Products Related to Preformed EPC Plain Liposomes with 45 mol% CHOL can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>
Product Specifications
Short Description
Catalog Number: B2019459 (5 mL)
Weight
0.8
Length
2
Width
0.9
Height
0.9
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items